127 related articles for article (PubMed ID: 1385373)
21. T cell can recognize the allospecificities formed by the substitution of amino acids associated with HLA-Bw4/Bw6 public epitopes.
Hiraiwa M; Yamamoto J; Matsumoto K; Karaki S; Nagao T; Kano K; Takiguchi M
Hum Immunol; 1991 Sep; 32(1):41-5. PubMed ID: 1723061
[TBL] [Abstract][Full Text] [Related]
22. Human leukocyte antigen-B (-Bw6/-Bw4 I80, T80) and human leukocyte antigen-C (-C1/-C2) subgrouping using pyrosequence analysis.
Ugolotti E; Vanni I; Raso A; Benzi F; Malnati M; Biassoni R
Hum Immunol; 2011 Oct; 72(10):859-68. PubMed ID: 21664941
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a new HLA-B18 allele, B*1806, which lacks expression of the Bw6 epitope.
Balas A; García-Sánchez F; Santos S; Lillo R; Merino JL; Vicario JL
Tissue Antigens; 1998 Dec; 52(6):579-82. PubMed ID: 9894858
[TBL] [Abstract][Full Text] [Related]
24. Characterization of a monoclonal anti-Bw4 antibody (Tü109): evidence for similar epitopes on the Bw4 and Bw6 antigens.
Müller C; Herbst H; Uchanska-Ziegler B; Ziegler A; Schunter F; Steiert I; Muller C; Wernet P
Hum Immunol; 1985 Dec; 14(4):333-49. PubMed ID: 2416720
[TBL] [Abstract][Full Text] [Related]
25. Characterization of two human IgM monoclonal antibodies reactive with HLA-B27.
Wölpl A; Toubert A; Siemoneit K; Eiermann TH; Neumayer H; Goldmann SF
Tissue Antigens; 1995 Oct; 46(4):305-12. PubMed ID: 8560449
[TBL] [Abstract][Full Text] [Related]
26. Effect of Bw4 and Bw6 epitope mismatches on antibody production, acute and chronic rejection, and graft survival in renal allografts.
Leffell MS; Kraus E; Racusen LC; Ratner LE; Charney D; Zachary AA
Transplantation; 2001 Aug; 72(3):433-7. PubMed ID: 11502972
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization of serologic recognition sites in the human HLA-A2 molecule.
Santos-Aguado J; Barbosa JA; Biro PA; Strominger JL
J Immunol; 1988 Oct; 141(8):2811-8. PubMed ID: 2459229
[TBL] [Abstract][Full Text] [Related]
28. The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes.
Wan AM; Ennis P; Parham P; Holmes N
J Immunol; 1986 Dec; 137(11):3671-4. PubMed ID: 2431040
[TBL] [Abstract][Full Text] [Related]
29. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes.
Duquesnoy RJ; Mulder A; Askar M; Fernandez-Vina M; Claas FH
Hum Immunol; 2005 Jul; 66(7):749-61. PubMed ID: 16112022
[TBL] [Abstract][Full Text] [Related]
30. Epitope mapping of human monoclonal antibodies to HLA-B27 by using natural and mutated antigenic variants.
Weyl D; Hansen T; Deschamps Y; Hannestad K; Toubert A
Hum Immunol; 1991 Aug; 31(4):271-6. PubMed ID: 1717416
[TBL] [Abstract][Full Text] [Related]
31. Anti-HLA-E mAb 3D12 mimics MEM-E/02 in binding to HLA-B and HLA-C alleles: Web-tools validate the immunogenic epitopes of HLA-E recognized by the antibodies.
Ravindranath MH; Pham T; El-Awar N; Kaneku H; Terasaki PI
Mol Immunol; 2011 Jan; 48(4):423-30. PubMed ID: 21145594
[TBL] [Abstract][Full Text] [Related]
32. A public HLA antigen associated with HLA-A9, Aw32, and Bw4.
Kostyu DD; Cresswell P; Amos DB
Immunogenetics; 1980; 10(5):433-42. PubMed ID: 22457917
[TBL] [Abstract][Full Text] [Related]
33. Modulation on immunogenicity by HLA-B27 subtype polymorphism.
Jaraquemada D; Galocha B; Aparicio P; Rojo S; Calvo V; López de Castro JA
Eur J Immunol; 1988 Dec; 18(12):1945-50. PubMed ID: 2464494
[TBL] [Abstract][Full Text] [Related]
34. Specificity of two anti-class I HLA monoclonal antibodies that block class I recognition by the NKB1 killer cell inhibitory receptor.
Gumperz JE; Paterson JC; Litwin V; Valiante N; Lanier LL; Parham P; Little AM
Tissue Antigens; 1996 Oct; 48(4 Pt 1):278-84. PubMed ID: 8946681
[TBL] [Abstract][Full Text] [Related]
35. RG1, a new murine monoclonal antibody recognizing a "supertypic" determinant on HLA-A molecules.
Pettersen RD; Hestdal K; Lee N; Geraghty DE; Valø ET; Lie SO; Gaudernack G
Tissue Antigens; 1995 Mar; 45(3):203-12. PubMed ID: 7539160
[TBL] [Abstract][Full Text] [Related]
36. HLA-B*0702 antibody epitopes are affected indirectly by distant antigen residues.
McCutcheon JA; Smith KD; Valenzuela A; Aalbers K; Lutz CT
Hum Immunol; 1993 Feb; 36(2):69-75. PubMed ID: 7681814
[TBL] [Abstract][Full Text] [Related]
37. A unique murine monoclonal antibody recognizing HLA-B53, B37, B51, B52, +/-B44.
Etessami S; Tarsitani C; Lias M; Broadous M; Conger N; Randol G; Delory M; Bahrami S; Lee JH
Hum Immunol; 2001 Jul; 62(7):732-8. PubMed ID: 11423180
[TBL] [Abstract][Full Text] [Related]
38. Antigenic determinants of the HLA-B7 molecule; Bw6- and B7-specific determinants are spatially separate.
Parham P
Immunogenetics; 1983; 18(1):1-16. PubMed ID: 6190743
[TBL] [Abstract][Full Text] [Related]
39. In vitro mutagenesis of HLA-B27. Substitution of an unpaired cysteine residue in the alpha 1 domain causes loss of antibody-defined epitopes.
Taurog JD; el-Zaatari FA
J Clin Invest; 1988 Sep; 82(3):987-92. PubMed ID: 2458390
[TBL] [Abstract][Full Text] [Related]
40. HLA-B67: a member of the HLA-B16 family that expresses the ME1 epitope.
Little AM; Domena JD; Hildebrand WH; Shen SY; Barber LD; Marsh SG; Bias WB; Parham P
Tissue Antigens; 1994 Jan; 43(1):38-43. PubMed ID: 7517584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
